Home
Products
Gene
mRNA Products
mRNAs for Cancer Vaccine Research
mRNAs for Cancer Vaccine Research

mRNAs for Cancer Vaccine Research

Seattle Genova is one of the leading providers of life sciences products, offering a wide range of products, including mRNA services. Advancement in therapeutic medicine, mRNA has remarkably outcast everything to solve puzzles in the research field. With the increasing demand for mRNA and the help of Ph.D. experts, Seattle Genova has succeeded in developing services on mRNAs for cancer vaccine research. We provide high-quality cost-friendly products to meet our customer’s needs. Seattle Genova offers antibodies, bioactive proteins, virus particles, mRNA products, Stable cell lines, and research use kits in this category.  

Compare
Catalog Number
Gene Name
Product Name
More
PSA
PSA Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0414
PSA Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding PSA was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0414-LNP
PSA Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
HPV E6/E7
HPV E6/E7 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0415
HPV E6/E7 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding HPV E6/E7 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0415-LNP
HPV E6/E7 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
CEACAM5
CEACAM5 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0416
CEACAM5 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding CEACAM5 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0416-LNP
CEACAM5 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
CEACAM5/B7-1/ICAM-1/LFA-3
CEACAM5/B7-1/ICAM-1/LFA-3 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0417
CEACAM5/B7-1/ICAM-1/LFA-3 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding CEACAM5/B7-1/ICAM-1/LFA-3 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0417-LNP
CEACAM5/B7-1/ICAM-1/LFA-3 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
gp100:209-217
gp100:209-217 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0418
gp100:209-217 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding gp100:209-217 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0418-LNP
gp100:209-217 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
gp100
gp100 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0419
gp100 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding gp100 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0419-LNP
gp100 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
MUC1
MUC1 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0420
MUC1 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding MUC1 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0420-LNP
MUC1 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
MUC-1/B7.1
MUC-1/B7.1 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0421
MUC-1/B7.1 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding MUC-1/B7.1 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0421-LNP
MUC-1/B7.1 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Melan-A(27-35)/gp100(280-288)/tyrosinase(1-9)/B7.1
Melan-A(27-35)/gp100(280-288)/tyrosinase(1-9)/B7.1 (CD80)/B7.2 (CD86) Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0422
Melan-A(27-35)/gp100(280-288)/tyrosinase(1-9)/B7.1 (CD80)/B7.2 (CD86) Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding Melan-A(27-35)/gp100(280-288)/tyrosinase(1-9)/B7.1 (CD80)/B7.2 (CD86) was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0422-LNP
Melan-A(27-35)/gp100(280-288)/tyrosinase(1-9)/B7.1 (CD80)/B7.2 (CD86) Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
NY-ESO-1
NY-ESO-1 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0423
NY-ESO-1 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding NY-ESO-1 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0423-LNP
NY-ESO-1 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Choose up to 4 products to compare
Compare
Clear All
0.245656s